Tecentriq

Solution for injection, 1875mg
RxActive license

Active substance (INN)

atezolizumab

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength1875mg
PackagingUkupno 1 bočica staklena sa 15ml rastvora za injekciju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FF05)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateOctober 30, 2024

Analogs in Montenegro

1

Other medicines with the same active substance

TECENTRIQRx
Concentrate for solution for infusion, 1200mgF. Hoffmann-La Roche AG
Source: CInMED register